Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$825M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$813M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
|
+$802M |
| 4 |
iShares MSCI India ETF
INDA
|
+$743M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 2 |
Microsoft
MSFT
|
+$2.08B |
| 3 |
NVIDIA
NVDA
|
+$1.74B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Netflix
NFLX
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.41% |
| 2 | Consumer Discretionary | 1.14% |
| 3 | Financials | 1.02% |
| 4 | Healthcare | 0.75% |
| 5 | Industrials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIG
8351
CALL
DELISTED
Big Lots, Inc.
BIG
| $122K | ﹤0.01% |
28,100
-33,300
| -54% | -$176K |
|
8352
CALL
AMC Global Media
AMCX
$489M
| $121K | ﹤0.01% |
10,000
-18,400
| -65% | -$279K |
|
|
ATYR
8353
aTyr Pharma
ATYR
$51.9M
| $121K | ﹤0.01% |
+62,140
| New | +$108K |
|
8354
ADC Therapeutics
ADCT
$144M
| $121K | ﹤0.01% |
26,984
-74,276
| -73% | -$274K |
|
|
RAYS
8355
DELISTED
Global X Solar ETF
RAYS
| $121K | ﹤0.01% |
10,290
-12,609
| -55% | -$147K |
|
8356
CALL
Maravai LifeSciences
MRVI
$895M
| $121K | ﹤0.01% |
+13,900
| New | +$94K |
|
|
ACB
8357
CALL
Aurora Cannabis
ACB
$179M
| $120K | ﹤0.01% |
27,360
+17,400
| +175% | +$67.3K |
|
|
HDSN
8358
PUT
Hudson Technologies
HDSN
$240M
| $120K | ﹤0.01% |
+10,900
| New | +$142K |
|
8359
PUT
BGC Group
BGC
$4.86B
| $120K | ﹤0.01% |
+15,400
| New | +$114K |
|
8360
Lindblad Expeditions
LIND
$2.16B
| $119K | ﹤0.01% |
12,795
-58,443
| -82% | -$538K |
|
8361
PUT
Pagaya Technologies
PGY
$1.8B
| $119K | ﹤0.01% |
11,812
+4,920
| +71% | +$69.9K |
|
|
EOD
8362
Allspring Global Dividend Opportunity Fund
EOD
$286M
| $119K | ﹤0.01% |
24,854
+6,557
| +36% | +$29.4K |
|
|
ESPR
8363
PUT
DELISTED
Esperion Therapeutics
ESPR
| $119K | ﹤0.01% |
44,400
+7,300
| +20% | +$17.7K |
|
|
VOXX
8364
DELISTED
VOXX International Corporation Class A
VOXX
| $119K | ﹤0.01% |
+14,556
| New | +$125K |
|
|
ESPR
8365
CALL
DELISTED
Esperion Therapeutics
ESPR
| $119K | ﹤0.01% |
44,300
-93,500
| -68% | -$227K |
|
8366
CALL
Perimeter Solutions
PRM
$5.65B
| $119K | ﹤0.01% |
+16,000
| New | +$86.1K |
|
|
HSAI
8367
CALL
Hesai Group
HSAI
$3.03B
| $118K | ﹤0.01% |
+23,400
| New | +$126K |
|
8368
PUT
Eos Energy Enterprises
EOSE
$1.47B
| $117K | ﹤0.01% |
113,800
-51,500
| -31% | -$52.4K |
|
|
EHAB
8369
CALL
DELISTED
Enhabit
EHAB
| $117K | ﹤0.01% |
+10,000
| New | +$100K |
|
|
PHK
8370
PIMCO High Income Fund
PHK
$878M
| $116K | ﹤0.01% |
+23,566
| New | +$116K |
|
8371
Outdoor Holding Co
POWW
$297M
| $116K | ﹤0.01% |
42,263
-81,400
| -66% | -$190K |
|
8372
CALL
Future Fuel
FF
$226M
| $116K | ﹤0.01% |
+14,400
| New | +$88.4K |
|
8373
OmniAb
OABI
$491M
| $116K | ﹤0.01% |
21,378
+4,084
| +24% | +$23.5K |
|
|
GBIO
8374
DELISTED
Generation Bio
GBIO
| $116K | ﹤0.01% |
2,842
-7,861
| -73% | -$185K |
|
|
8375
PUT
Maravai LifeSciences
MRVI
$895M
| $115K | ﹤0.01% |
+13,300
| New | +$90K |
|
Similar funds
Jane Street's Q1 2024 Portfolio in Review
As of Q1 2024, Jane Street held 10,498 positions worth $478B, up 25% from $384B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Jane Street deployed $55.3B of net new capital in Q1 2024, opening 1,391 new positions and adding to 3,225 existing holdings. Its largest new stake was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 4.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.37B trimmed.
- Jane Street's largest Q1 2024 buy was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
- Jane Street added most to iShares MSCI ACWI ETF in Q1 2024, an estimated $825M increase.
- Jane Street's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.37B.
- Jane Street fully exited JPMorgan Ultra-Short Income ETF in Q1 2024, selling an estimated $302M.
- Jane Street's ten largest holdings make up 51% of its $478B portfolio in Q1 2024.
- Jane Street opened 1,391 new positions and closed 1,402 in Q1 2024.
- Jane Street's portfolio value rose 25% quarter-over-quarter to $478B.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.